Sai Parenterals Ltd Quarterly Result
Sai Parenterals Ltd
NSE: SAIPARENT
Net Profit - Last Quarter
Sai Parenterals Ltd Quarterly Results Key Highlights
- The revenue of Sai Parenterals Ltd for the Mar '26 is ₹ 200.81 crore as compare to the Mar '25 revenue of ₹ 99.28 crore.
- This represent the growth of 102.27% The ebitda of Sai Parenterals Ltd for the Mar '26 is ₹ 28.97 crore as compare to the Mar '25 ebitda of ₹ -0.43 crore.
- This represent the decline of -6837% The net profit of Sai Parenterals Ltd for the Mar '26 is ₹ 13.16 crore as compare to the Mar '25 net profit of ₹ -6.66 crore.
- This represent the decline of -297%.
Sai Parenterals Ltd Quarterly Results Analysis
Market Price of Sai Parenterals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 29 Jul 2026 | 552.1 |
| 28 Jul 2026 | 546.65 |
| 27 Jul 2026 | 560.6 |
| 24 Jul 2026 | 538.05 |
| 23 Jul 2026 | 539.9 |
| 22 Jul 2026 | 550.85 |
| 21 Jul 2026 | 560.4 |
| 20 Jul 2026 | 568.25 |
| 17 Jul 2026 | 556.8 |
| 16 Jul 2026 | 569.8 |
Historical Revenue of Sai Parenterals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Sai Parenterals Ltd
Historical EBITDA of Sai Parenterals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Sai Parenterals Ltd
Historical Net Profit of Sai Parenterals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Sai Parenterals Ltd
Sai Parenterals Ltd News Hub
Sai Parenteral's IPO subscribed 41%
The initial public offer (IPO) of Sai Parenteral's received bids for 30,82,788 shares as against 75,
Read more
25 Mar 26
Sai Parenterals arm signs OTC medicines supply agreement with Australian pharmacy network
Sai Parenterals announced that the company's subsidiary Noumed Pharmaceuticals had entered OTC medic
Read more
01 Jul 26
Sai Parenteral's to convene board meeting
Sai Parenteral's will hold a meeting of the Board of Directors of the Company on 20 April 2026.
Read more
15 Apr 26
Sai Parenteral's IPO subscribed 1.01 times
The initial public offer (IPO) of Sai Parenteral's received bids for 78,80,972 shares as against 75,
Read more
27 Mar 26
Popular Search
About Sai Parenterals Ltd
- Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad.
- Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022. Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets.
- Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas.
